COVID-19 and Ivermectin: Potential threats associated with human use.

Abstract:

:Drugs re-purposing due to COVID-19 virus has declared a number of useful candidates for treatment and prevention of the virus. Ivermectin (IVM) has gained much popularity due to a strong background of magical applications against a broad spectrum of pathogens. The in- vitro studies of ivermectin have shown promise, the thorough clinical trials of its efficacy in the treatment and prevention of SARS-CoV-2 are still warranted. Useful strategies for analyzing projected use of IVM in human coronaviruses might be developed. It may be done by concluding ongoing clinical trials and culturing lessons from IVM usage in veterinary practice. The potential toxicity and careful dosage analyses are urgently required before declaring it as an anti-SARS-CoV-2 drug candidate. This manuscript overviews the background and potential threats associated with the off-label use of IVM as prophylactic drug or treatment option against COVID-19 virus.

journal_name

J Mol Struct

authors

Zaheer T,Pal K,Abbas RZ,Torres MDPR

doi

10.1016/j.molstruc.2021.130808

keywords:

["CVID-19 virus","Drug analysis","Ivermectin","Safety","Threats"]

subject

Has Abstract

pub_date

2021-11-05 00:00:00

pages

130808

eissn

0022-2860

issn

1872-8014

pii

S0022-2860(21)00941-8

journal_volume

1243

pub_type

杂志文章